Skip to main content

Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.

European heart journal2025-02-18PubMed
Total: 81.5Innovation: 8Impact: 9Rigor: 8Citation: 8

Summary

In 7,319 surgical AVR patients (median follow-up 12.6 years), PPM was more prevalent in women (31.9% vs 19.7%) and associated with higher all-cause (HR 1.30) and cardiovascular mortality (HR 1.39). After adjustment, VARC-3 PPM remained independently associated with outcomes only in women, while sex-specific spline-derived EOAi thresholds linked PPM with outcomes in both sexes.

Key Findings

  • PPM was more prevalent in women vs men (31.9% vs 19.7%, P<0.0001); severe PPM was rare but more frequent in women (2.4% vs 0.6%).
  • PPM associated with all-cause mortality (HR 1.30, 95% CI 1.20-1.40) and cardiovascular mortality (HR 1.39, 95% CI 1.23-1.57).
  • After multivariable adjustment, VARC-3 PPM remained independently associated with outcomes only in women.
  • Spline-derived sex-specific EOAi thresholds linked PPM with outcomes in both sexes, suggesting higher thresholds may be needed in men.

Clinical Implications

Surgeons should consider sex-specific EOAi thresholds to minimize PPM risk, particularly in women. Preoperative planning and prosthesis selection may change to achieve better effective orifice matching and outcomes.

Why It Matters

Findings support sex-specific EOAi thresholds to define PPM and improve long-term risk stratification after AVR, potentially informing prosthesis sizing and guideline criteria.

Limitations

  • Observational design with potential residual confounding.
  • Single regional health system; external generalizability needs validation.

Future Directions

External validation of sex-specific EOAi thresholds across diverse populations and integration into surgical planning tools; assess impact on reoperation, symptoms, and quality of life.

Study Information

Study Type
Cohort
Research Domain
Prognosis
Evidence Level
III - Large observational cohort with long-term outcomes provides prognostic evidence.
Study Design
OTHER